ORI — Orion Nutraceuticals Balance Sheet
0.000.00%
HealthcareMicro Cap
Annual balance sheet for Orion Nutraceuticals, fiscal year end - May 31st, CAD millions except per share, conversion factor applied.
2022 May 31st | 2023 May 31st | 2024 May 31st | 2025 May 31st | 2026 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.009 | 0.004 | 0.193 | 0.091 | 0.053 |
| Net Total Receivables | 0 | — | — | — | — |
| Prepaid Expenses | |||||
| Total Current Assets | 0.009 | 0.004 | 0.193 | 0.092 | 0.053 |
| Total Assets | 0.009 | 0.004 | 0.193 | 0.092 | 0.053 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 0.646 | 0.919 | 1.17 | 1.23 | 1.06 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 0.645 | 0.918 | 1.17 | 1.23 | 1.06 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -0.635 | -0.914 | -0.976 | -1.14 | -1.01 |
| Total Liabilities & Shareholders' Equity | 0.009 | 0.004 | 0.193 | 0.092 | 0.053 |
| Total Common Shares Outstanding |